dichloromethane. The combined organic layers were dried over
sodium sulfate, filtered, and evaporated.
3-methyl-[1,2,3]triazolo[1,5-a] pyridine (5a; 1.0 g 45%) as a
◦
1
colorless solid. mp 93–95 C. – H NMR (300 MHz, CDCl3):
d = 7.56 (d, J = 8.2 Hz, 1 H, H4), 7.15–7.00 (m, 2 H, H6 + H5),
2.73–2.57 (m, 2 H, PCy2), 1.94 (dd, J = 16.5, 8.6 Hz, 2 H, PCy2),
1.72 (d, J = 7.5 Hz, 2 H, PCy2), 1.53 (m, 4H, PCy2), 1.14 (m, 12 H,
PCy2). – 13C NMR (75 MHz, CDCl3): d = 137.1 (d, J = 41.2 Hz,
1C, C7) 134.2 (s, 1 C, C3), 131.5 (s, 1 C, C3a), 124.1 (d, J = 25.9 Hz,
1 CH, C6), 122.5 (d, J = 9 Hz, 1 CH. C5), 117.8 (s, 1 CH, C4),
32.4 (d, J = 11 Hz, 2 CH, (CH)-PCy2), 30.9 (d, J = 19 Hz, 2 CH2,
CH2), 29.9 (d, J = 9 Hz, 2 CH2, CH2), 26.7 (d, J = 3.2, Hz, 2 CH2,
CH2), 26.6 (bs, 2 CH2, CH2), 26.2–25.9 (bs, 2 CH2, CH2), 10.4 (s,
CH3). – 31P (161 MHz, CDCl3): d = 6.5. – MS (EI): m/z(%) = 329.2
(35) [M+], 301.2 (33) [M+ - N2], 246. (81) [M+ - Cy], 218.2 (100)
[M+ - N2 - Cy], 137 (66) [M+ - N2 - 2Cy]. – HRMS for C19H28N3P
[M+Li]: calcd. 336.2176; found 336.2215.
7-(Diphenylphosphino)-3-methyl-[1,2,3]triazolo[1,5-a]pyridine
(4a). Starting from 3-methyl-[1,2,3]triazolo[1,5-a] pyridine (3a,
1.0 g, 7.5 mmol) in toluene (50 mL). The crude product was pu-
rified by filtration on silicagel to afford 7-(diphenylphosphino)-3-
methyl-[1,2,3]triazo◦lo[1,5-a]pyridine (4a; 1.0 g, 42%) as a colorless
1
solid. mp 142–144 C. – H NMR (300 MHz, CDCl3): d = 7.60
(d, J = 8.8 Hz, 1 H, H4), 7.45–7.30 (m, 10 H, PPh2), 7.05 (dd, J =
8.8, 6.9 Hz, 1 H, H5), 6.37 (d, J = 6.8 Hz, 1 H, H6), 2.62 (s, 3 H,
CH3). – 13C NMR (75 MHz, CDCl3): d = 138.4 (d, J = 22 Hz, C7)
134.5 (d, J = 1.2 Hz, 1 C, C3), 134.2 (d, J = 21 Hz, 4 CH, o-Ph),
132.6 (d, J = 8,3 Hz, 2 C, ipso-Ph), 131.3 (s, 1 C, C3a), 129.7 (s, 2
CH, p-Ph), 128.84 (d, J = 7.7 Hz, 4 CH, m-Ph), 123.1 (s, CH, C5),
120.8 (s, CH, C6), 117.2 (s, CH, C4), 10.5 (s, CH3). – 31P NMR
(161 MHz, CDCl3): d = -15.4. – MS (EI): m/z(%) = 317.1 (63)
[M+], 288 (100) [M+ - N2], 212.1 (39) [M+ - N2 - Ph], 183.1 (93).
– HRMS for C19H17N3P: calcd. 318.1155; found 318.1145.
7-(Dicyclohexylphosphino)-[1,2,3]triazolo[1,5-a]pyridine (5b).
Starting from [1,2,3]triazolo[1,5-a]pyridine (3b, 0.4 g, 3.4 mmol)
in toluene (17 mL). The crude product was purified by filtration on
silicagel to afford 7-(dicyclohexylphosphino)-[1,2,3]triazolo[1,5-
a]pyridine (5b; 0.6 g, 58%) as a colorless solid. mp 124–126 ◦C.
7-(Diphenylphosphine)-[1,2,3]triazolo[1,5-a]pyridine
(4b).
Starting from [1,2,3]triazolo[1,5-a]pyridine (3b, 0.4 g, 3.4 mmol)
in toluene (17 mL). The crude product was purified by filtration
on silicagel to afford 7-(diphenylphosphine)-[1,2,3]triazolo[1,5-
a]pyridine (4b, 0.5 g, 44%) as a colorless solid. mp 160–162 ◦C. –
1H NMR (300 MHz, CDCl3): d = 7.98 (d, J = 2.4 Hz, 1 H, H3),
7.61 (d, J = 8.8 Hz, 1 H, H4), 7.30–7.21 (m, 10 H, PPh2), 7.01
1
– H NMR (300 MHz, CDCl3): d = 8.07 (s, 1 H, H3), 7.73–7.65
(m, 1 H, H4), 7.21–7.10 (m, 2 H, H5 + H6), 2.72–2.55 (m, 2 H,
CH-PCy2), 2.02–1.90 (m, 2 H, CH2), 1.79–1.70 (m, 2 H, CH2),
1.63–1.51 (m, 4 H, CH2), 1.35, 1.16 (m 10 H, CH2). – 13C NMR
(75 MHz, CDCl3): d = 137.1 (d, J = 41.8 Hz, 1 C, C7), 133.7 (s,
1 C, C3a), 125.6 (s, 1 C, C3), 124.6 (d, J = 25.9 Hz, 1 CH, C6),
124.1(d, J = 8.2 Hz, 1 CH, C5), 118.2 (s, 1 CH, C4), 32.6 (d, J =
11.3 Hz, 2 CH, (CH)-PCy2), 30.9 (d, J = 19.1 Hz, 2 CH2, CH2),
30.0 (d, J = 9.0 Hz, 2 CH2, CH2), 26.7 (d, J = 3.6 Hz, 2 CH2,
CH2), 26.6 (s, 2 CH2, CH2), 26.8 (d, J = 1.1 Hz, 2 CH2, CH2). –
31P NMR (161 MHz, CDCl3): d = 7.0. – MS (EI): m/z(%) = 315.2
(42) [M+], 287.2 (33) [M+ - N2], 232.1 (57) [M+ - Cy], 204.2 (100)
[M+ - N2 - Cy], 151.1 (45) [M+ - 2Cy + 2H], 123 (25) [M+ - N2
- 2Cy + 2H]. – HRMS for C18H26N3P [M + Li]: calcd. 322.2019;
found 322.1975.
(dd, J = 8.8, 6.9 Hz, 1 H, H5), 6.32 (d, J = 6.8 Hz, 1 H, H6). – 13
C
NMR (75 MHz, CDCl3): d = 138.5 (d, J = 22.4 Hz, 1 C, C7) 133.9
(d, J = 21.1 Hz, 4 CH, o-Ph), 133.2 (s, 1 C, C3a), 132.3 (d, J =
8.2 Hz, 2 CH, ipso-Ph), 129.6 (s, 2 CH, p-Ph) 128.7 (d, J = 7.8 Hz,
4 CH, m-Ph), 125.6 (d, J = 1.6 Hz, 1 C, C3), 124.5 (s, 1 CH, C5),
120.8 (s, 1 CH, C6), 117.2 (s, 1 CH, C4). – 31P NMR (161 MHz,
CDCl3): d = -15.0. – MS (EI): m/z(%) = 303.1 (78) [M+], 275.1
(10) [M+ - N2], 274.1 (55) [M+ - N2 - H], 198.1 (23) [M+ - N2 -
Ph], 183.1 (93). – HRMS for C18H14N3P: [M+H+] calcd. 304.0998;
found 304.0969.
7-(Diphenylphosphino)-3-phenyl-[1,2,3]triazolo[1,5-a] pyridine
(4c). Starting from 3-phenyl-[1,2,3]triazolo[1,5-a] pyridine (3c,
0.4 g, 2.1 mmol) in toluene (14 mL). The crude product was
purified by filtration on silicagel to afford 7-(diphenylphosphine)-
[1,2,3]triazolo[1,5-a]pyridine (4c; 1.1 g, 52%) as a yellow oil. – 1H
NMR (300 MHz, CDCl3): 7.98 (m, 3 H, H4 + 3-o-Ph), 7.52–7.33
(m, 13 H, PPh2 + 3-m-Ph + 3-p-Ph), 7.17 (dd, J = 8.8, 6.9 Hz, 1 H,
H5), 6.45 (d, J = 6.9 Hz, 1 H, H6). – 13C NMR (75 MHz, CDCl3):
d = 139.3 (d, J = 23.3 Hz, 1 C, C7), 137.8 (d, J = 1.9 Hz, 1 C, C3),
134.2 (d, J = 21.2 Hz, 4 CH, P(o-Ph)2), 132.4 (d, J = 8.3 Hz, 2 C,
ipso-PPh2), 131.6 (s, 1 C, C3a), 130.2 (s, C, 3-ipso-Ph), 129.8 (s,
2 C, P(p-Ph)2), 128.9 (d, J = 7.8 Hz, 4 CH, P(m-Ph)2), 128.8 (s,
2 CH. 3-o-Ph), 127.7 (s, 1 CH, 3-p-Ph), 126.6 (s, 2 CH, 3-m-Ph),
7-(Dicyclohexylphosphino)-3-phenyl-[1,2,3]triazolo[1,5-a] pyri-
dine (5c). Starting from 3-phenyl-[1,2,3]triazolo[1,5-a] pyridine
(3c, 0.3 g, 1.3 mmol) in toluene (25 mL). The crude product was pu-
rified by filtration on silicagel to afford 7-(dicyclohexylphosphino)-
3-methyl-[1,2,3]triazolo[1,5-a] pyridine (5c; 0.3 g, 52%) as a
◦
1
colorless solid. mp 93–95 C. – H NMR (300 MHz, CDCl3):
d 8.00 (m, 3 H, H4 + 3-o-Ph), 7.51 (J = 7.6, 7.6 Hz, 2 H, 3-m-Ph),
7.37 (m, 1 H, 3-p-Ph), 7.25–7.20 (m, 2 H, H5 + H6), 2.82–2.60 (m,
2 H, CH-PCy2), 2.02–1.91 (m, 2 H, CH2), 1.81–1.70 (m, 3 H, CH2),
1.63–1.51 (m, 5 H, CH2), 1.39–1.04 (m 10 H, CH2). – 13C NMR
(75 MHz, CDCl3): d = 137.8 (s, 1 C, C3), 137.6 (d, J = 44.5 Hz,
1 C, C7), 131.7 (s, 1 C, C3a), 130.7 (s, 1 C, 3-ipso-Ph), 128.9 (s, 2
CH, 3-o-Ph) 127.7 (s, CH, 3-p-Ph), 126.6 (s, 2 CH, 3-m-Ph), 125.1
(d, J = 27.6 Hz, 1 CH, C6), 24.6 (d, J = 8.7 Hz, 1 CH, C5), 118.8
(s, 1 CH, C4), 32.7 (d, J = 27.6 Hz, 2 CH, (CH)-PCy2), 31.1 (d,
J = 19.3 Hz, 2 CH2, CH2), 30.2 (d, J = 9.0 Hz, 2 CH2, CH2), 26.9
(s, 2 CH2, CH2), 26.8 (d, J = 3.5 Hz, 2 CH2, CH2), 26.7 (s, 2 CH2,
CH2), 26.2 (s, 2 CH2, CH2). – 31P NMR (161 MHz, CDCl3): d =
6.5. – MS (EI): m/z(%) = 391.2 (25) [M+], 363.2 (80) [M+ - N2],
280. (100) [M+ - N2 -Cy], 199.1 (90), 146.1 (90). – HRMS for
C24H30N3P [M + O + Li]: calcd. 414.2280; found. 414.2270.
124.9 (s, 1 CH, C5), 120.9 (s, 1 CH, C6), 117.9 (s, 1 CH, C4). – 31
P
NMR (161 MHz, CDCl3): d = -14.6. – MS (EI): m/z(%) = 379.1
(8) [M+], 351.1.1 (37) [M+ - N2], 350.1 (20) [M+ - N2 - H], 185.1
(72) [P(Ph)2], 183.1 (100). – HRMS for C24H18N3P: [M+O+Li+]
calcd. 402.1343; found 402.1316.
7-(Dicyclohexylphosphino)-3-methyl-[1,2,3]triazolo[1,5-a] pyri-
dine (5a). Starting from 3-methyl-[1,2,3]triazolo[1,5-a] pyridine
(3a, 1.0 g, 7.5 mmol) in toluene (50 mL). The crude product was pu-
rified by filtration on silicagel to afford 7-(dicyclohexylphosphino)-
This journal is
The Royal Society of Chemistry 2011
Dalton Trans., 2011, 40, 1387–1395 | 1393
©